Inozyme Pharma, Inc. (INZY)
Jul 1, 2025 - INZY was delisted (reason: acquired by BMRN)
4.000
0.00 (0.00%)
Inactive · Last trade price on Jun 30, 2025
Inozyme Pharma Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$15.22
Upside
+280.50%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $4 | Buy → Hold | Downgrades | $4 | n/a | May 16, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $15 → $4 | Strong Buy → Hold | Downgrades | $15 → $4 | n/a | May 16, 2025 |
| Needham | Needham | Strong Buy → Hold Downgrades $12 | Strong Buy → Hold | Downgrades | $12 | +200.00% | May 16, 2025 |
| Needham | Needham | Strong Buy Maintains $15 → $12 | Strong Buy | Maintains | $15 → $12 | +200.00% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +300.00% | Apr 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +275.00% | Apr 8, 2025 |
| Raymond James | Raymond James | Buy Maintains $24 → $12 | Buy | Maintains | $24 → $12 | +200.00% | Mar 12, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $23 | Buy | Maintains | $30 → $23 | +475.00% | Mar 11, 2025 |
| Needham | Needham | Strong Buy Maintains $23 → $15 | Strong Buy | Maintains | $23 → $15 | +275.00% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +300.00% | Mar 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $43 → $30 | Buy | Maintains | $43 → $30 | +650.00% | Jan 13, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +175.00% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +300.00% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +300.00% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +250.00% | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +475.00% | Nov 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.